Journal of Commercial Biotechnology

Editorial: Creating a competitive European life science sector
pp. 1-4(4)
Author: Fisken, Jane

Financing papers: The role of the European Commission in fostering innovation in the life sciences and biotechnology
pp. 6-14(9)
Authors: Kütt, Waldemar; Magnien, Etienne; Cantley, Mark

Commercial biotechnology in Germany: An overview
pp. 15-21(7)
Authors: Bialojan, Siegfried; Schüler, Julia

What will it take to get institutional investors interested in life sciences again?
pp. 22-28(7)
Author: Brooks, William

Consolidation challenges in Europe's life science sector - Making it happen
pp. 29-34(6)
Author: Stoiber, Wolfgang

Riposte: FDA response to `Yin, yang and the biopharmaceutical industry'
pp. 36-39(4)
Authors: Rosenberg, Amy S; Weiss, Karen D; Lanthier, Michael; Eastep, Roger; Egan, William; Goodman, Jesse L; Woodcock, Janet

The Sarbanes-Oxley Act and non-US issuers: Considerations for international companies
pp. 40-53(14)
Author: Gates, Megan N

Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances
pp. 54-59(6)
Author: Ratliff, Alan

The impact of pharmacogenetics and pharmacogenomics
pp. 60-77(18)
Author: Lindpaintner, Klaus

A new model to evaluate the market for biotechnology
pp. 78-84(7)
Authors: McMurray, Amanda; Jones, Richard

Biotechnology M&A insight: Deals and strategies
pp. 85-91(7)
Author: Pavlou, Alex K

Legal and regulatory update: Legal and regulatory update
pp. 92-103(12)

Financial accounts reports
pp. 104-106(3)
Author: Citron, David

Biotech Alliances: Bridging the R&D Gap
pp. 107-108(2)
Author: Scott, Nerida

Additional on-line material: Pharmacoeconomics and the growth of the biotechnology industry
pp. 109-120(12)
Authors: Szucs, Thomas D; Schneeweiss, Sebastian